B
Bull
Bull · 25%CV
$5.79
Precio del escenario
$5.870
+0.030 (+0.51%)Al cierre
Loading chart…
- High
- 5.970
- Open
- 5.800
- VWAP
- 5.88
- Vol
- 62.21K
- Mkt Cap
- —
- Low
- 5.785
- Amount
- 365.51K
- EV/EBITDA, TTM
- -7.09
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.
AI analysis of CapsoVision Inc (CV)
buyCapsoVision Inc is a good buy right now, trading at $5.93 with a forward P/E of 0 and a gross margin of 51.36%. The recent 10% revenue growth in Q2 2026 and the positive analyst ratings suggest strong potential for recovery and growth. However, the main risk is the net income loss of $7.48 million in Q2 2026, which indicates ongoing financial challenges.
Métricas de valoración
The current forward P/E ratio for CapsoVision Inc (CV) is 0.00, compared to its 5-year average forward P/E of -10.86.
Alphio AI Price Scenarios for CV
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Cronología de eventos
Noticias
9.508-14Yahoo FinanceCapsoVision Reports 10% Revenue Growth in Q2 2026
9.508-04NASDAQ.COMCRISPR Therapeutics Reports Narrowed Loss in Q2 2026
5.008-04NASDAQ.COMCapsoVision Launches AI Highlights for Capsule Endoscopy Studies
5.008-03GlobenewswireCapsoVision Launches AI Highlights for Capsule Endoscopy
5.008-03NewsfilterCapsoVision Launches AI Highlights for Capsule Endoscopy
CV FAQ — answered by Alphio AI
CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule. It operates in the Healthcare sector.
CapsoVision Inc is a good buy right now, trading at $5.93 with a forward P/E of 0 and a gross margin of 51.36%. The recent 10% revenue growth in Q2 2026 and the positive analyst ratings suggest strong potential for recovery and growth. However, the main risk is the net income loss of $7.48 million in Q2 2026, which indicates ongoing financial challenges.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.